AnalystBook Research · Company Intelligence

Oaktree Acquisition Corp. III Life Sciences

OACCNasdaq

Built from Oaktree Acquisition Corp. III Life Sciences's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

    Leadership changes

    From Oaktree Acquisition Corp. III Life Sciences's own filings, the day they're filed.

    • George A. Martinez · Chief Financial Officer · appointmenteff. 2025-10-29
    • Life Sciences · Chief Financial Officer · departureeff. 2025-10-29
    • David A. Berry · director · departureeff. 2025-10-17

    Latest filings

    • 10-Q · Quarterly report2026-08-12
    • 10-Q · Quarterly report2026-05-13
    • 10-K · Annual report2026-03-26
    • 10-Q · Quarterly report2025-11-13
    • 8-K · Company announcement2025-10-29
    In the full recordFree for 14 days
    • The filings, readable — with what changed vs the prior year highlighted🔒
    • Full financial statements, industry-aware, sources cited throughout🔒
    • Forensic score history & components — the trend, not one year🔒
    • Ownership: insider buys/sells, clusters, activist stakes🔒
    • Ana — ask about Oaktree Acquisition Corp. III Life Sciences, every answer cited to the official filings🔒
    • The Intelligence Brief — added when Oaktree Acquisition Corp. III Life Sciences's brief passes our SEC-figure check🔒

    Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

    14-day free trial, no credit card. For research purposes only; not investment advice.